Symptomatic therapy and neurorehabilitation in multiple sclerosis

@article{Kesselring2005SymptomaticTA,
  title={Symptomatic therapy and neurorehabilitation in multiple sclerosis},
  author={J{\"u}rg Kesselring and Serafin Beer},
  journal={The Lancet Neurology},
  year={2005},
  volume={4},
  pages={643-652}
}
Multiple sclerosis (MS) is associated with a variety of symptoms and functional deficits that result in a range of progressive impairments and handicap. Symptoms that contribute to loss of independence and restrictions in social activities lead to continuing decline in quality of life. Our aim is to give an updated overview on the management of symptoms and rehabilitation measures in MS. Appropriate use of these treatment options might help to reduce long-term consequences of MS in daily life… 
NEUROREHABILITATION STRATEGIES IN MULTIPLE SCLEROSIS
TLDR
Inpatient and outpatient multidisciplinary rehabilitation has been shown to be beneficial in improving disability and Neurorehabilitation methods are important tools in developing complex management strategies for patients with multiple sclerosis.
Clinical Implications of Neuroplasticity – The Role of Rehabilitation in Multiple Sclerosis
TLDR
An overview of the most recent scientific evidence and measures of MS rehabilitation, and the relationship between neuroplasticity and functional improvement in MS is given.
Neurorehabilitation in Persons with Multiple Sclerosis: Scientific Basis and Options of Treatment
TLDR
Rehabilitation is effective in mitigating disability and improving QoL in persons with MS.
Rehabilitation interventions in multiple sclerosis: an overview
TLDR
Comprehensive assessment of health domains in MS patients using standardized framework and common language for describing the impact of disease at different levels, using International Classification of Functioning, Disability and Health core sets may increase the knowledge of needs of these patients for more efficient and adapted rehabilitation interventions meeting these individual requirements.
Multiple Sclerosis Neurorehabilitation in Multiple Sclerosis – Resilience in Practice
I n recent years, enormous strides have been made in increasing the range and efficacy of disease-modifying drugs available for the treatment of multiple sclerosis (MS) in its early and remitting
[Multiple sclerosis : rehabilitation and long-term course].
  • S. Beer, J. Kesselring
  • Medicine
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
  • 2014
TLDR
Rehabilitation measures should be considered in an early phase of the disease for maintaining functional abilities and reducing the risk of progression of disabilities, according to an often unpredictable change of disease activity.
[Neurorehabilitation in multiple sclerosis].
TLDR
The conceptual basis for neurore rehabilitation will be presented together with a review of the literature concerning the biological aspects of neurorehabilitative therapy (neuroplasticity) and the clinical trials evaluating the effectiveness of Neurorehabilitation in people with multiple sclerosis.
Autoimmune diseases and rehabilitation.
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
TLDR
Inclusion of neuroprotective drugs aimed at preventing axonal, neuronal, myelin and oligodendrocyte damage and cell death that are approved and others that are currently in clinical trials are discussed, with an emphasis on human derived natural antibodies with remyleination potential.
Exercise in multiple sclerosis -- an integral component of disease management
TLDR
The current knowledge on the influence of physical activity and exercise on disease-related symptoms and physical restrictions in MS patients is summarized.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 86 REFERENCES
Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis?
TLDR
It is suggested that inpatient rehabilitation is useful in RR MS, particularly in patients with incomplete recovery from relapses who have accumulated moderate to severe disability.
Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients
TLDR
It is demonstrated that a short outpatient rehabilitation treatment improves disability of MS patients, without changing their impairment and confirms the effectiveness of rehabilitation in people with MS.
Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients
TLDR
It is demonstrated that a short outpatient rehabilitation treatment improves disability of MS patients, without changing their impairment and confirms the effectiveness of rehabilitation in people with MS.
A multimodal approach to managing the symptoms of multiple sclerosis
TLDR
The symptom management model that provides optimal results for patients with MS is a multimodal approach using effective communication, patient education, physical modalities and activities, occupational and other therapies, and pharmacologic interventions.
The impact of inpatient rehabilitation on progressive multiple sclerosis
TLDR
Despite unchanging impairment, inpatient rehabilitation resulted in reduced disability and handicap in patients with progressive MS.
Physical rehabilitation has a positive effect on disability in multiple sclerosis patients
TLDR
Despite unchanging impairment, physical rehabilitation resulted in an improvement in disability and had a positive impact on mental components of health-related quality of life perception at 3 and 9 weeks.
Cognitive Dysfunction in Multiple Sclerosis
TLDR
In diagnosing cognitive dysfunction in a patient with MS, it is important first to recognise and treat the common comorbidities of fatigue and depression, and to delay disease progression.
Prevalence and treatment of spasticity reported by multiple sclerosis patients
TLDR
In the focused survey, ITBG reported lower levels of spasticity than ORALG, less stiffness in the legs, less pain and fewer spasms at any time, which can significantly impact QOL parameters by reducing spasms, pain and fatigue.
Cognitive dysfunction in multiple sclerosis.
TLDR
It is suggested that cognitive dysfunction is a major factor in determining the quality of life of patients with MS.
Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin
Pain is a well-recognized and disabling symptom in patients with MS. In one large clinical series, 55% of MS patients experienced acute or chronic pain at some time during their illness.1 Chronic
...
1
2
3
4
5
...